Biohit Oyj (HEL:BIOBV)
Finland
· Delayed Price · Currency is EUR 2.380
-0.070 (-2.86%)
At close: Mar 9, 2026
Biohit Oyj Revenue
In the year 2025, Biohit Oyj had annual revenue of 15.70M EUR with 9.92% growth. Biohit Oyj had revenue of 8.30M in the half year ending December 31, 2025, with 26.22% growth.
Revenue
15.70M
Revenue Growth
+9.92%
P/S Ratio
2.30
Revenue / Employee
341.30K
Employees
46
Market Cap
36.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.70M | 1.42M | 9.92% |
| Dec 31, 2024 | 14.28M | 1.21M | 9.23% |
| Dec 31, 2023 | 13.08M | 2.13M | 19.40% |
| Dec 31, 2022 | 10.95M | 1.59M | 16.99% |
| Dec 31, 2021 | 9.36M | 2.24M | 31.42% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orion Oyj | 1.89B |
| Terveystalo Oyj | 1.28B |
| Revenio Group Oyj | 109.90M |
| Pihlajalinna Oyj | 652.30M |
| Nightingale Health Oyj | 4.79M |
| Aiforia Technologies Oyj | 4.08M |
| Nexstim | 12.41M |
| Nanoform Finland Oyj | 5.02M |